Year
2025202420232022202120202019201820172016201520142013201220112009200820072006200520042003200220012000
Edition number
№20 (213)№18-19 (212)№16 (210)№15 (209)№14 (208)№13 (207)№12 (206)№11 (205)№10 (204)№9 (203)№8 (202)№7 (201)№6 (200)№5 (199)№4 (198)№3 (197)№2 (196)№1 (195)
№17 (211) / 2010
V.V. Fomin
V.F. Semiglazov, V.V. Semiglazov, V.G. Ivanov, A.A. Bessonov, D.Ye. Shchedrin, Ye.K. Zhiltsova, G.A. Dashyan, R.M. Paltuev, T.Yu. Semiglazova, K.D. Penkov, A.G. Vasilyev
Adjuvant Anti-her2 Therapy For Breast Cancer12-17
V.F. Kasatkin, A.V. Snezhko, V.S. Trifanov, Yu.A. Fomenko, Kh.G. Mamoulian
Extirpation Of The Esophagus With Right Extended Hemihepatectomy For Stromal Gastrointestinal Tumor18-21
V.F. Semiglazov, V.V. Semiglazov, A.A. Bessonov, R.M. Paltuev, K.Yu. Zernov, K.D. Penkov
Main Results Of Clinical Research In Oncology In First Half Of The Year 201022-25
V.I. Borisov
Effectiveness Of Afinitor® (everolimus) For Metastatic Kidney Cancer26-33
A.F. Urmancheeva
Avastin (bevacizumab) In The Treatment Of Ovarian Cancer34-37
T.Yu Semiglazova, L.V. Filatova, D.Kh Latipova, M.L. Gershanovich
Target Therapy Her2-positive Breast Cancer With Brain Metastases: New Prospects For Treatment38-43
N.V. Dobrova
Xeloda In The Treatment Of Metastatic Colorectal Cancer44-50
S.L. Gutorov, Ye.I. Borisova
Maintenance Therapy In Stages Iiib-iv Non-small-cell Lung Cancer51-55
L.G.Zhukova, K.A. Vorontsova
Sunitinib In The Treatment Of Patients With Progression Of Gastrointestinal Stromal Tumors After Use Of Imatinib (gleevec)56-60
B.V. Kholodov, R.T. Abdullaev, Ye.M. Tarasova, S.K. Gorelyshev, L.V. Shishkina, O.G. Zheludkova, O.V. Klimchuk, O.I. Shcherbenko, A.G. Prityko
Monoclonal Antibodies Bevacizumab (avastin (r)) In Combination Therapy Of Poorly Differentiated Glial Tumors Of Central Nervous System In Children (literature Review And Own Experience)61-66
N.V. Dmitriyev, N.S. Bagirova, Z.V. Grigoryevskaya, I.A. Ryabov, S.A. Dyakova, I.N. Petukhova
Febrile Neutropenia In Oncological Patients68-77
N.V. Zhukov
Drug Zometa In Addition To The Chemotherapy Significantly Increases Overall Survival In Previously Untreated Patients With Multiple Myeloma78-80
A.N. Kazyulin, L.Z. Vel’cher, I.A. Koroleva
Hepatotoxicity During Anticancer Chemotherapy Of Oncological Diseases And Methods Of Its Correction82-90
G.L. Kobyakov, A.V. Smolin, O.V. Absalyamova, R.D. Amanov, S.V. Strazhev
Mustophoran In The Treatment Of Malignant Gliomas: Results Of Prospective Pilot Study91-96
L.Yu. Vladimirova, N.A. Abramova, A.E Storozhakova, A.L. Paly
Resorba In The Treatment Of Bone Metastasis Of Breast Cancer97-100
V.A. Hailenko, S.M. Mihailov, R. Hasanov, D.A. Lybennikov, E.A. Gotovkin, Helen Yin, E.A. Sholohov
Phase Ii Study Of Combination Of Pemetrexed (alimta®) And Cisplatin As First-line Treatment Of Stage Iv Stomach Cancer Or Recurrent Gastric Cancer101-108
N.I. Stuklov, S.A. Levakov, N.S. Vanke, S.V. Strazhev
Characteristics Of Anemia Associated With Diseases Of The Female Reproductive System, Recommendations For Treatment109-114
M.I. Volkova
Conference Of Renal Cancer Experts: A Review Of Materials115-119
